The effect of phacoemulsification underneath nucleus fragments on reducing corneal damage for treating dense cataract

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031114

Enrollment

Unknown

Registered

2020-03-22

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

1:Phacoemulsification for cataract surgery

2:phacoemulsification underneath nucleus fragments on reducing corneal damage for treating dense cataract

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: From March 2020 to September 2020, the patients were diagnosed as senile cataract. According to the hardness of nucleus, they were graded as IV-V, aged 50-80 years old

Exclusion criteria

Exclusion criteria: Exclude systemic chronic diseases, such as hypertension, diabetes, renal insufficiency, anemia, etc., and exclude patients with uveitis, glaucoma, fundus retinal disease history. The patients with other history of intraocular surgery such as glaucoma, vitreoretinal surgery, corneal endothelial count less than 1200 / mm2 and those who were unwilling or unable to follow up were excluded.

Design outcomes

Primary

Measure	Time frame
Corneal Thickness;Corneal Endothelial Cells;Visual Auity;	—

Countries

China

Contacts

Public ContactZeng Mingbing

Hainan Eye Hospital, Zhongshan Ophthalmic Center, Sun Yat-Sen University

zengmingbing@126.com+86 15308912010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026